EP 4165190 A1 20230419 - COMPOSITIONS AND METHODS OF MANUFACTURING AUTOLOGOUS T CELL THERAPIES
Title (en)
COMPOSITIONS AND METHODS OF MANUFACTURING AUTOLOGOUS T CELL THERAPIES
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR HERSTELLUNG AUTOLOGER T-ZELLTHERAPIEN
Title (fr)
COMPOSITIONS ET PROCÉDÉS DE FABRICATION DE THÉRAPIES DE LYMPHOCYTES T AUTOLOGUES
Publication
Application
Priority
- US 202063038516 P 20200612
- US 202163161283 P 20210315
- US 2021037012 W 20210611
Abstract (en)
[origin: WO2021252898A1] The present disclosure relates to methods, cells, and compositions for preparing cells and compositions for genetic engineering and cell therapy. Provided in certain embodiments are streamlined cell preparation methods, e.g., for isolation, processing, incubation, and genetic engineering of cells and populations of cells. Also provided are cells and compositions produced by the methods and methods of their use.
IPC 8 full level
C12N 15/63 (2006.01); C07K 14/725 (2006.01); C07K 16/28 (2006.01); C12N 15/90 (2006.01)
CPC (source: EP)
A61K 39/4611 (2023.05); A61K 39/4632 (2023.05); A61K 39/464401 (2023.05); A61P 35/00 (2018.01); C07K 14/7051 (2013.01); C12N 5/0636 (2013.01); C12N 15/907 (2013.01); C12N 2310/20 (2017.05); C12N 2501/2307 (2013.01); C12N 2501/2315 (2013.01); C12N 2501/51 (2013.01); C12N 2501/515 (2013.01); C12N 2510/00 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021252898 A1 20211216; AU 2021288213 A1 20230202; CA 3181117 A1 20211216; EP 4165190 A1 20230419; EP 4165190 A4 20240925
DOCDB simple family (application)
US 2021037012 W 20210611; AU 2021288213 A 20210611; CA 3181117 A 20210611; EP 21821421 A 20210611